|
Synonyms: BMS-986016 | BMS986016 | ONO-4482 | Opdualag® (nivolumab + relatlimab-rmbw) | relatlimab-rmbw
relatlimab is an approved drug (EMA & FDA (2022))
Compound class:
Antibody
Comment: Relatlimab (BMS-986016) is an anti-LAG3 monoclonal antibody that was developed for utility in cancer immunotherapy.
|
| Immunopharmacology Comments |
| BMS-986016 is an immunomodulatory monoclonal antibody targeting the inhibitory receptor, T cell co-stimulatory protein, LAG3. |
